AI-Powered Implantable Cardioverter-Defibrillator (ICD) System with Integrated Substernal Pacing Lead

An implantable cardioverter-defibrillator (ICD) system integrating AI, IoT, blockchain, and nanomaterial technologies to provide personalized cardiac arrhythmia detection, treatment, and monitoring, enhancing patient outcomes and improving healthcare efficiency.

The original patent disclosed an implantable cardioverter-defibrillator (ICD) system including a substernal pacing lead. However, the system lacked the ability to provide real-time cardiac activity monitoring, personalized pacing pulses, and optimized defibrillation protocols. The new inventive concept addresses these limitations by integrating AI-powered ECG analysis, blockchain-based data storage, IoT-enabled communication, and nanomaterial-based sensors, enabling a more effective and efficient cardiac arrhythmia treatment system.

The AI-powered ICD system comprises a substernal pacing lead integrated with an AI-powered ECG analyzer, which identifies arrhythmia patterns and triggers the substernal pacing lead to deliver personalized pacing pulses. The system also incorporates a blockchain-based data storage system to securely store and analyze patient-specific cardiac data, generating optimized defibrillation protocols based on the analyzed data. Additionally, the system features a nanomaterial-based sensor for real-time cardiac activity monitoring and an IoT-enabled communication module for transmitting the monitored data to a remote healthcare provider. The system can also utilize machine learning-based cardiac rhythm classification and neural network-based algorithm for analyzing patient-specific cardiac data and generating personalized pacing and defibrillation protocols.

The new inventive concept introduces the synergistic combination of AI, IoT, blockchain, and nanomaterial technologies with the substernal pacing lead, providing a novel and non-obvious solution for personalized cardiac arrhythmia detection, treatment, and monitoring. The inventive step lies in the integration of these distinct technologies to create a more effective and efficient cardiac arrhythmia treatment system.

Alternative embodiments of the inventive concept may include the use of different AI algorithms, IoT communication protocols, blockchain architectures, or nanomaterial-based sensors. Variations of the system may also include the integration of additional technologies, such as wearable devices or cloud-based data analytics, to further enhance the system's capabilities.

The AI-powered ICD system has significant commercial potential in the medical device industry, particularly in the areas of cardiac arrhythmia treatment and remote patient monitoring. The system's ability to provide personalized treatment and real-time monitoring can improve patient outcomes, reduce healthcare costs, and enhance the overall efficiency of cardiac care services.